17. Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med; 1995; 25(3): 404-6. 28. Garratty G, Leger RM, Arndt PA. Severe inmune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol. 1999; 181(1): 103-4.
29. Koga K, Murakami M, Kawashima S. Effects of fatty acid glycerol esters on intestinal absorptive and secretory transport of ceftibuten. Biol. Pharm Bull; 1999; 22(4): 402-6.
30. Rosenfeld E, Shaughnessy AF, Weart W, et al. When to use the newer beta-lactam antibiotics. Patient Care. 1995; 29(14): 119-32.
31. Ou MC, Ng HT, Tzeng CR. Sonographically guided intralesional antobiotic inyection for treatment of a recalcitrant pelvicabscess: a case report. J Obstet Gynaecd Res. 1999; 25(3): 205-7.
32. Raeissi SD, Li J, Hidalgo IJ. The role of an alpha-aminogroup on H+-dependent transepithelial transport of cephalosporins in Caco-2 cells. Journal Announcement. 1999; 51(1): 35-40.
33. Babálová M, Blahová J, Hupková M, et al. Peroral preparations of cephalosporin antibiotics. Cas Lek Cesk. 1994; 133(1): 22-4.
34. Tomita T, Takamo M, Yasuhara M, et al. Transport of oral cephalosporins bu the H+ / dipeptide contrasporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells. J Pharmacol Exp ther; 1995; 272(1): 63-9.
35. Maraspin V, Lotric-Furlan S, Strle F. Ceftriaxone associated hemolysis. Journal Announcement. 1999; 111(9): 368-70.
36. Rodríguez WJ, Khan W, Sait T, et al: Cefixime vs. cefaclorin the treatment of acute otitis media in children: A randomized, comparative study. Pediatr Infect Dis J. 1993; 12: 70-74.
37. Sun AH, Parnes LS, Freeman DJ. Comparative perilymph permeability of cephalosporins and its significance in the treatment and prevention of suppurative labyrinthitis. Ann Otol Thinol Laryngol. 1996; 105(1): 54-7.